SXRN Injection for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Oct 2026: Trial registered, NCT07890324

The trials

NCT07890324: A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia

State
Not started
Phase
Phase 2
People
96 planned
Started
Dec 2026
Primary completion
Aug 2027
Arms
4 mg SXRN, 6 mg SXRN
Results
None posted
  1. 22 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.